BIOSTRIKE

Please join us for a LIVE chat today with the NEUROSENSE team! It’s about their research into #SUDEP detection and prevention! They are a great couple of guys: João Ferreira and Miguel França! Join for free on this 👇🏻 link at 15:30 GMT / 10:30 EST today! https://lnkd.in/eAysCic4

Today is SUDEP Action Day! 🌍✨ On this significant day, we come together to raise awareness about Sudden Unexpected Death in Epilepsy (#SUDEP). BIOSTRIKE is proud to be part of the NEUROSENSE_EU Project, dedicated to tackling this critical issue. Join us in supporting families and advocates as we strive to understand the risks associated with SUDEP. Watch Prof. Sándor Beniczky from the Danish Epilepsy Centre share insights into our ongoing efforts to tackle SUDEP. Together, let’s pave the way for a future where SUDEP can be prevented! 💪💙 #SUDEPActionDay2024 #OurRisksOurRights #Biostrike #NEUROSENSE

Inspiring discussions and great progress reported at the #Neurosense annual meeting, in Dianalund! And a nice run in the forest next to the hospital :) #epilepsy #SUDEP #wearables ERN EpiCARE - Rare and Complex Epilepsies Filadelfia Epilepsihospital og sociale tilbud NEUROSENSE_EU BIOSTRIKE i3S - Instituto de Investigação e Inovação em Saúde João Ferreira Miguel França Massimo Mantegazza Onur Parlak Philippe Ryvlin

Exciting Day at the Third NEUROSENSE Summit in Denmark! Today, the NEUROSENSE Consortium gathered at the renowned Filadelfia Epilepsihospital og sociale tilbud in Dianalund for our third summit, marking crucial progress in our mission to predict and prevent SUDEP (Sudden Unexpected Death in Epilepsy). We had the privilege of visiting the state-of-the-art Epilepsy Monitoring Unit (EMU), where advanced diagnostic and monitoring work is done for complex epilepsy cases. It was truly inspiring to witness the groundbreaking efforts of our esteemed colleagues, Sándor Beniczky and Sidsel Armand Larsen. Through their expertise, we gained valuable insights into the patient journey, reinforcing the importance of keeping patient needs at the center of our innovation process. This summit serves as a pivotal moment to assess our progress and strategize the next steps in developing the world’s first predictive medical device for SUDEP. We are excited to continue our collaboration with partners and the epilepsy community to ensure that our research translates into real-world impact, empowering patients and caregivers alike. Stay tuned for more updates from this important event! #EpilepsyResearch #SUDEP #PatientCentricity #Neurosense #Innovation #EpilepsyCare #EIC

🔬 Introducing the NEUROSENSE Research Team Series! 🚀 As we return refreshed and energized after the summer break, we're excited to kick off a new series highlighting the incredible research institutions that are integral to the NEUROSENSE project. These teams have been hard at work, and their dedication is key to our mission of developing a SUDEP (Sudden Unexpected Death in Epilepsy) predictive medical device prototype. 🔬 Spotlight on i3S: Pioneering Research in Health The Institute for Research and Innovation in Health (i3S - Instituto de Investigação e Inovação em Saúde) is a leading private non-profit biomedical research unit renowned for its multidisciplinary approach and strategic partnerships with U.Porto schools, major hospitals in Northern Portugal, and key players in the health sector. This collaborative environment fosters groundbreaking research, particularly in cancer, infectious diseases, neurological disorders, and regenerative medicine. i3S's Role in NEUROSENSE: At the heart of the NEUROSENSE project, i3S is home to a talented team focused on sample bioanalysis. Led by Hugo Osório, Head of the Proteomics Facility, and PhD students Ana Pinto Branco Teixeira and Nelson Leça, the team meticulously processes and analyzes mouse and human samples using state-of-the-art Liquid Chromatography–Mass Spectrometry (LC-MS). Key members Carlos Conde (Project Coordinator) and Miguel França a (Project Manager) are also instrumental in ensuring the seamless execution of the NEUROSENSE initiative, contributing significantly to our efforts to predict and prevent SUDEP. Stay tuned as we continue to showcase the brilliant minds driving NEUROSENSE forward! #NEUROSENSEProject #EpilepsyResearch #SUDEP #Innovation #i3S #BiomedicalResearch

🚨 Exciting Announcement for the 2024 NEUROSENSE Summit! 🚨 We are thrilled to announce that the 2024 NEUROSENSE Summit will be held at the prestigious Filadelfia Epilepsy Hospital in Dianalund, Denmark. This year, we are embracing a hybrid format to ensure everyone can participate, whether in person or remotely. 📅 Dates: October 5, 2024 🏥 Location: Filadelfia Epilepsy Hospital, Dianalund, Denmark The theme of this year’s summit is “Focus to Gather.” Our aim is to channel our collective energy and expertise to achieve groundbreaking outcomes in the second half of the NEUROSENSE project. We are on a mission to identify the first SUDEP (Sudden Unexpected Death in Epilepsy) predictive biomarker and develop the first SUDEP Predictive Medical Device. During this summit, the NEUROSENSE Consortium will come together in person, while our advisory board will join us remotely. This setup will enable us to leverage the strengths of both physical and virtual collaboration. Let’s work together to make this summit a milestone in epilepsy research and patient care! #NEUROSENSE2024 #EpilepsyResearch #SUDEP #HybridSummit #FocusToGather #PatientCentric

🌟✨ Celebrating Innovation and Collaboration: Biostrike Joins International Rare Disease Day 2024 ✨🌟 As a proud member of the NEUROSENSE Research Consortium, Biostrike is thrilled to commemorate International Rare Disease Day on February 29th, 2024. This significant day resonates deeply with our commitment to advancing groundbreaking solutions for rare neurological conditions, including epilepsy and SUDEP (Sudden Unexpected Death in Epilepsy). At Biostrike, we are honored to contribute our expertise and innovative technologies to the NEUROSENSE project, which aims to develop the world's first SUDEP Predictive Medical Device (SMD). This initiative exemplifies our dedication to making a tangible difference in the lives of individuals affected by rare diseases. International Rare Disease Day serves as a powerful reminder of the importance of collaboration, innovation, and compassion in addressing the unique challenges faced by those living with rare neurological disorders. As part of the NEUROSENSE Research Consortium, Biostrike is privileged to stand alongside leading experts and organizations in driving progress and raising awareness for rare diseases. Today, we celebrate the resilience and strength of individuals and families impacted by rare diseases worldwide. Together, let's continue to champion innovation and collaboration to pave the way for a brighter future for all. #RareDiseaseDay #NEUROSENSE #Biostrike #EpilepsyAwareness #Innovation #RareDiseaseAwareness #HealthcareRevolution 🌐🧠